High-Dose Once-Weekly Semaglutide: A New Option for Obesity Management.

Courtney L BradleySara M McMillinAndrew Y Hwang Christina H Sherrill

Published in: The Annals of pharmacotherapy (2021)

High-dose once-weekly semaglutide can significantly reduce weight, and although gastrointestinal adverse effects were common, it is generally well tolerated.

Keyphrases

high dose
weight loss
stem cell transplantation
low dose
weight gain
insulin resistance
metabolic syndrome
body mass index
type diabetes
physical activity
high fat diet induced
adipose tissue